Petros Pharmaceuticals, Inc. (PTPI)

Petros Pharmaceuticals Balance Sheet

Financials in millions USD. Fiscal year is January - December.

Fiscal Year	FY 2024	FY 2023	FY 2022	FY 2021	FY 2020
Period Ending	Dec 31, 2024	Dec 31, 2023	Dec 31, 2022	Dec 31, 2021	Dec 31, 2020
Cash & Equivalents	3.71	13.34	9.43	23.85	17.14
Cash & Short-Term Investments	3.71	13.34	9.43	23.85	17.14
Cash Growth	-72.18%	41.49%	-60.47%	39.14%	698.75%
Accounts Receivable	0.42	2.23	2.11	2.46	5.15
Other Receivables	-	-	-	0.61	-
Receivables	0.42	2.23	2.11	3.06	5.15
Inventory	3	2.79	1.82	0.52	0.76
Prepaid Expenses	0.16	1.22	0.51	1.58	1.37
Other Current Assets	0.01	0.82	0.8	1.53	1.48
Total Current Assets	7.29	20.39	14.67	30.54	25.91
Property, Plant & Equipment	0.14	0.26	0.4	0.52	0.64
Other Intangible Assets	3.2	8.97	12.24	25.29	32.16
Other Long-Term Assets	-	4.18	5.11	11.03	11.14
Total Assets	10.64	33.8	32.42	67.39	69.85
Accounts Payable	2.33	1.71	1.81	4.56	5.61
Accrued Expenses	1.29	1.18	1.32	3.5	2.96
Current Portion of Long-Term Debt	7.25	1.16	1.09	-	7.18
Current Portion of Leases	0.06	0.13	0.14	0.13	0.11
Other Current Liabilities	7.1	6.59	2.71	22.8	26.04
Total Current Liabilities	18.03	10.77	7.07	30.98	41.89
Long-Term Debt	-	6.86	8.39	-	-
Long-Term Leases	0.08	0.14	0.26	0.41	0.53
Other Long-Term Liabilities	-	3.55	0	0.46	9.96
Total Liabilities	18.1	21.32	15.72	31.85	52.38
Common Stock	0	0	0	0	0
Additional Paid-In Capital	105.74	110.96	107.43	106.23	79.17
Retained Earnings	-113.21	-98.89	-90.73	-70.69	-61.7
Total Common Equity	-7.47	12.07	16.7	35.54	17.47
Shareholders' Equity	-7.47	12.48	16.7	35.54	17.47
Total Liabilities & Equity	10.64	33.8	32.42	67.39	69.85
Total Debt	7.39	8.28	9.88	0.53	7.81
Net Cash (Debt)	-3.68	5.06	-0.46	23.32	9.33
Net Cash Growth	-	-	-	150.05%	-
Net Cash Per Share	-0.46	2.33	-0.22	21.41	17.46
Filing Date Shares Outstanding	53.52	6.88	2.09	2.07	0.98
Total Common Shares Outstanding	10.53	2.99	2.08	2.07	0.97
Working Capital	-10.73	9.62	7.6	-0.44	-15.99
Book Value Per Share	-0.71	4.04	8.03	17.18	18.00
Tangible Book Value	-10.67	3.1	4.46	10.25	-14.69
Tangible Book Value Per Share	-1.01	1.04	2.14	4.96	-15.13

Updated Nov 13, 2024. Source: S&P Global Market Intelligence. Standard template. Financial Sources.

SEC Filings: 10-K · 10-Q